Alcon AG | ALC - Assets


Alcon AG reported $31.56B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AstraZeneca USD 114.07B 382M Dec/2025
Bayer EUR 104.54B 331M Dec/2025
Essilor EUR 63.9B 1.97B Dec/2025
Fresenius EUR 42.46B 1.14B Sep/2025
Fresenius Medical Care EUR 31B 115.33M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
GRIFOLS EUR 19.71B 141.77M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 51.53B 600M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Philips EUR 26.94B 605M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Smith & Nephew USD 10.69B 150M Dec/2025
Sonova Holding CHF 5.92B 468.2M Jun/2025
UCB EUR 18.16B 971M Dec/2025